Clinical Activity of Osimertinib in EGFR Mutation Positive Non-Small Cell Lung Cancer (NSCLC) Patients (Pts) Previously Treated with Rociletinib Gadgeel, S., Chen, W., Piotrowska, Z., Goldman, J. W., Wakelee, H., Camidge, D., Varga, A., Yu, H., Papadimitrakopoulou, V., Nea, J., Soria, J., Wozniak, A., Riely, G., Narayanan, V., Mendenhal, M., Sequist, L. ELSEVIER SCIENCE INC. 2017: S1263

View details for Web of Science ID 000413055803032